Evidence map›Paper›PMID 40048065›Full record

ArticleDermatology and therapy2025

Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials.

April W Armstrong, Matthias Augustin, Jennifer L Beaumont, Tan P Pham, Stacie Hudgens, Kenneth B Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M Kisa and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatology and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

April W ArmstrongKeck School of Medicine of University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0003-0064-8707
Matthias AugustinInstitute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Jennifer L BeaumontClinical Outcomes Solutions, Tucson, AZ, USA.ORCID http://orcid.org/0000-0002-1484-260X
Tan P PhamClinical Outcomes Solutions, Tucson, AZ, USA.ORCID http://orcid.org/0000-0002-5862-5658
Stacie HudgensClinical Outcomes Solutions, Tucson, AZ, USA.ORCID http://orcid.org/0000-0002-7350-1549
Kenneth B GordonMedical College of Wisconsin, Milwaukee, WI, USA.
Joe ZhuoBristol Myers Squibb, 3401 Princeton Pike, Princeton, NJ, 08648, USA. joe.zhuo@bms.com.
Brandon BeckerBristol Myers Squibb, 3401 Princeton Pike, Princeton, NJ, 08648, USA.
Yichen ZhongBristol Myers Squibb, 3401 Princeton Pike, Princeton, NJ, 08648, USA.
Renata M KisaBristol Myers Squibb, 3401 Princeton Pike, Princeton, NJ, 08648, USA.
Subhashis BanerjeeBristol Myers Squibb, 3401 Princeton Pike, Princeton, NJ, 08648, USA.ORCID http://orcid.org/0009-0000-1365-5207
Kim A PappAlliance Clinical Trials and Probity Medical Research, Waterloo, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40048065
PMCPMC11971066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.